PCL Microspheres

Short Description:

PCL microspheres have been widely used in medical applications, especially in the field of cosmetic and plastic surgery. They can be injected subcutaneously to stimulate collagen production and improve skin elasticity, resulting in a natural-looking volumizing and rejuvenating effect.


  • CAS: 24980-41-4
  • Molecular weight specification for viscosity average: 8,000-12,000; 30,000-50,000; 50,000-70,000
  • Molecular weight distribution: ≤2.0
  • Particle size specification: 20μm~40μm;20μm~50μm;30μm~50μm;40μm~60μm
  • Particle Size Customization: 10μm~100μm
  • Particle size span value: ≤0.7

Product Detail

PCL microspheres have been widely used in medical applications, especially in the field of cosmetic and plastic surgery. They can be injected subcutaneously to stimulate collagen production and improve skin elasticity, resulting in a natural-looking volumizing and rejuvenating effect. Due to its extensive range of uses, PCL microspheres hold great promise in revolutionizing medical treatment methods, providing healthcare practitioners with more accurate, secure, and efficient treatment options while simultaneously ensuring patients a more pleasant and hassle-free experience.
Product Index:

Item Unit Standard 
Reference Standard Method Result
Appearance / / / Optical Microscopy Spherical particle
Median Size(D50) μm 35±5 / Laser Particle Size Analyzer 34.35
Span / ≤0.7 / Laser Particle Size Analyzer 0.612
Intrinsic Viscosity [η] dL/g 0.50±0.05 GB/T 37642-2019 25±0.02 °C, 0.01 g/mL THF Solution, 0.47 mm Inside Diameter of Automatic Ubbelohde Viscometer 0.526
Moisture % ≤ 0.5 GB/T 37642-2019 Karl Fischer Coulometric Titration 0.13
Monomer Residue % ≤ 2.0 / GC 0.11
Solvent Residue ppm ≤1000 / GC Qualified
Heavy Metal Residue (Pb) μg/g ≤10(Except Sn) YY/T 0661-2017 Colorimetric Method of Chinese Pharmacopoeia Qualified
Catalyst Residual μg/g Sn≤150 YY/T 0661-2017 US EPA 3052:1996 & US EPA6010D2018 65

 *Produced in GMP workshop, each batch will provide the corresponding COA report.

Model No. Intrinsic Viscosity [η] (dL/g) Particle size range
MP-PCL02A 0.20-0.26 20-50
MP-PCL04A 0.35-0.43 20-50
MP-PCL08A 0.70-0.90 20-50
MP-PCL12A 1.00-1.30 20-50
MP-PCL04B 0.35-0.43 25-50

With complete microsphere preparation capabilities:

*PLA/PCL synthetic design and GMP production

*Excellent formulation and process development capabilities

*Excellent excipient customization ability and GMP grade excipient production

*Multifunctional synthesis laboratory

 

Medical processing service field

The processing technology of polybiotic micropowder can serve medical beauty, drug sustained release, targeted drug delivery, cosmetics and other medical related fields.


  • Previous:
  • Next:

  • Write your message here and send it to us